Bilateral Cardiac Sympathetic Denervation on an ECMO patient for
Refractory Ventricular arrhythmia: A Case Report.
Genetic syndromes such as Brugada syndrome can lead to lethal
ventricular arrhythmias. Cardiac Sympathetic Denervation has been shown
to be effective in ameliorating refractory ventricular arrhythmias. We
present a 33-year-old black female with a past medical history of
Brugada syndrome with an implantable cardiac defibrillator (ICD), who
presented with refractory ventricular tachycardia/atrial fibrillation
leading to heart failure and cardiogenic shock, requiring Extracorporeal
membrane oxygenation (ECMO). The patient subsequently underwent
bilateral stellate ganglion sympathetic denervation in the setting of
refractory ventricular arrhythmias. We present this case report to
showcase that thoracoscopic bilateral sympathetic denervation can be an
effective definitive treatment option for ventricular arrhythmias that
remain refractory to medical management.